PubMed:7542286 / 445-628 JSONTXT

Annnotations TAB JSON ListView MergeView

    jnlpba-st-training

    {"project":"jnlpba-st-training","denotations":[{"id":"T7","span":{"begin":50,"end":68},"obj":"protein"},{"id":"T8","span":{"begin":86,"end":92},"obj":"protein"}],"text":"In a concentration-dependent manner, NO inhibited interleukin (IL)-1 alpha-stimulated VCAM-1 expression by 35-55% as determined by cell surface enzyme immunoassays and flow cytometry."}

    genia-medco-coref

    {"project":"genia-medco-coref","denotations":[{"id":"C12","span":{"begin":37,"end":39},"obj":"NP"},{"id":"C13","span":{"begin":50,"end":75},"obj":"NP"}],"text":"In a concentration-dependent manner, NO inhibited interleukin (IL)-1 alpha-stimulated VCAM-1 expression by 35-55% as determined by cell surface enzyme immunoassays and flow cytometry."}

    pubmed-sentences-benchmark

    {"project":"pubmed-sentences-benchmark","denotations":[{"id":"S4","span":{"begin":0,"end":183},"obj":"Sentence"}],"text":"In a concentration-dependent manner, NO inhibited interleukin (IL)-1 alpha-stimulated VCAM-1 expression by 35-55% as determined by cell surface enzyme immunoassays and flow cytometry."}

    GENIAcorpus

    {"project":"GENIAcorpus","denotations":[{"id":"T14","span":{"begin":5,"end":35},"obj":"other_name"},{"id":"T15","span":{"begin":37,"end":39},"obj":"inorganic"},{"id":"T16","span":{"begin":50,"end":68},"obj":"protein_molecule"},{"id":"T17","span":{"begin":86,"end":92},"obj":"protein_molecule"},{"id":"T18","span":{"begin":131,"end":163},"obj":"other_name"},{"id":"T19","span":{"begin":168,"end":182},"obj":"other_name"}],"text":"In a concentration-dependent manner, NO inhibited interleukin (IL)-1 alpha-stimulated VCAM-1 expression by 35-55% as determined by cell surface enzyme immunoassays and flow cytometry."}